Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been officially diagnosed with NK/T-cell lymphoma through laboratory testing, as defined by the 2016 World Health Organization classification
- People aged between 14 and 70 years old
- People whose general physical health and ability to carry out daily activities falls within an acceptable range for the trial (a standard medical scoring system is used to measure this — confirm with trial site)
- People who are expected to live for at least 6 months
- People who have not yet received any treatment for NK/T-cell lymphoma
- People who are willing and able to follow all study procedures throughout the entire trial
- People who have provided written consent to participate
Who may not be able to join:
- People who have been diagnosed with aggressive NK cell leukemia
- Women who are pregnant or breastfeeding
- People who have reduced liver or kidney function
- People who cannot safely have a PET/MR scan, including those who: have an implanted electronic device such as a pacemaker; have certain metal implants in the body, such as some types of aneurysm clips; have an implanted device that delivers medication, such as an insulin pump; are unable to cooperate with the scan due to conditions such as being unconscious, having a serious mental illness, or being critically unwell; or have a fear of enclosed spaces (claustrophobia)
- People who have other serious or uncontrolled health conditions that the trial doctors believe would affect their ability to participate
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +862164370045
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The sensitivity, specificity and accuracy of PET/MR in the staging of newly diagnosed NK/T-cell lymphoma patients; The sensitivity, specificity and accuracy of PET/MR in the efficacy evaluation of newly diagnosed NK/T-cell lymphoma patients
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.